PERHAPS it is best to introduce this discussion with a few general statements to clarify the position which we have maintained throughout the past years. We have held that anticoagulant therapy for myocardial infarction does not constitute tlhe ultimate, the comprehensive, or even an entirely satisfactory form of therapy for this condition. If research directed at the prevention or reversal of ...

Welcome to a very special issue of Seminars in Thrombosis & Hemostasis. This issue, on the topic of “Anticoagulant therapy: present and future,” is guest edited by Job Harenberg, a longtime member of the editorial board and supporter of the journal. Indeed, Dr. Harenberg most recently wrote a historical sketch for the journal around the many meetings that he organized on the anticoagulant and n...